Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).

导出原文传递

翻译打印收藏纠错

作者： S E C,Pichardo ^[1] ; J G,van der Hee ^[2] ; M,Fiocco ^[3] ; N M,Appelman-Dijkstra ^[4] ; J P R,van Merkesteyn ^[5]

作者单位： Department of Oral & Maxillofacial Surgery (Chair: Prof. Dr. JPR van Merkesteyn), Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, The Netherlands; Center for Bone Quality Leiden, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, The Netherlands. ^[1] Department of Oral & Maxillofacial Surgery (Chair: Prof. Dr. JPR van Merkesteyn), Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, The Netherlands. ^[2] Department of Biomedical Data Sciences, Leiden University Medical Center, P.O. Box 9512, 2300 RA Leiden, The Netherlands; Mathematical Institute, Leiden University, P.O. Box 9512, 2300 RA Leiden, Leiden The Netherlands. ^[3] Department of Internal Medicine, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, The Netherlands; Center for Bone Quality Leiden, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, The Netherlands. ^[4] Department of Oral & Maxillofacial Surgery (Chair: Prof. Dr. JPR van Merkesteyn), Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, The Netherlands; Center for Bone Quality Leiden, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, The Netherlands. Electronic address: j.p.r.van_merkesteyn@lumc.nl. ^[5]

关键词 BRONJ DRONJ Dental implants MRONJ bisphosphonates denosumab osteomyelitis osteonecrosis risk factor

主题词骨密度保护剂(Bone Density Conservation Agents);牙种植体(Dental Implants);二膦酸盐类(Diphosphonates);人类(Humans);回顾性研究(Retrospective Studies);危险因素(Risk Factors)

DOI 10.1016/j.bjoms.2020.03.022

PMID 32631756

发布时间 2020-12-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交